IMS
Click for more information
0.00% 69.0¢ impelus limited

Ann: Market Update, page-2

  1. Cleo
    7,830 Posts.
    lightbulb Created with Sketch. 4
    clock Created with Sketch.
    08/08/17
    09:43
    Post #: 26354295
    FY 2017 Full year revenue and EBITDA guidance met • MBE continues to invest in and focus on higher EBITDA margin Performance Marketing division which is growing favourably • Balance sheet solid and underpins MBE’s operations
    MBE Price at posting: 7.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 11  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

TLG Talga to form joint venture with lithium producer SQM to develop Sweden's Aero project
right-arrow Created with Sketch.
NEWS From the Floor: Perth conference highlights
right-arrow Created with Sketch.
WAF West African Resources draws final US$100M from Sprott-backed loan for gold plant
right-arrow Created with Sketch.
BOT US FDA approves Botanix Pharma's excessive underarm sweat drug
right-arrow Created with Sketch.
IMU Imugene doses first cancer patient in Oasis trial
right-arrow Created with Sketch.
NEWS Money and Investing: Talking the minefield of divorce & family law
right-arrow Created with Sketch.
watchlist Created with Sketch. Add IMS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.